JusticeItaly Official institution
Italy changes marketing permission for Proplex blood-clotting medicine
Italy's medicines agency, AIFA, has published an official notice changing the marketing authorization for Proplex, a medicine made from human prothrombin complex (a group of blood-clotting proteins). A marketing authorization is the official permission that allows a drug to be sold. The notice in this excerpt does not explain what the change is.
This summary was generated by AI; the official source prevails.
What does it mean?
Proplex is a medicine used to help blood clot, and its official sales permission in Italy has been changed. The short notice does not say what changed, so the details are only in the full official document.
Who is affected?
Patients who use Proplex and the people who prescribe, supply or sell it in Italy.